Abstract

My comments today, and I will use the normal reservation of speakers, are my own. I have written on this topic—sovereign immunity and central bank immunity in the United States—in an article1 in which, again, the views expressed were my own and not necessarily those of the Federal Reserve Bank of New York. And in my presentation today, I do not want to get too deeply into the technical aspects of sovereign immunity itself, which are spelled out in the article. I would like to highlight some of those issues. What I hope I can add are a few practical suggestions, drawn from our experience over the past several years with respect to sovereign immunity.